Literature DB >> 23622776

Impact of 5-alpha reductase inhibitors on men followed by active surveillance for prostate cancer: a time-dependent covariate reanalysis.

Lih-Ming Wong, Neil Fleshner, Antonio Finelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23622776     DOI： 10.1016/j.eururo.2013.04.018

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  3 in total

1.  Pre-radiotherapy PSA progression is a negative prognostic factor in prostate cancer patients using 5‑alpha-reductase inhibitors.

Authors:  Daniel Taussky; Julie Piotte; Kevin C Zorn; Marc Zanaty; Vimal Krishnan; Carole Lambert; Jean-Paul Bahary; Marie-Claude Beauchemin; Maroie Barkati; Cynthia Ménard; Guila Delouya
Journal:  Strahlenther Onkol       Date:  2017-07-10       Impact factor: 3.621

2.  5-Alpha Reductase Inhibitors and Prostate Cancer Mortality among Men with Regular Access to Screening and Health Care.

Authors:  Mark A Preston; Lorelei A Mucci; Jane B Vaselkiv; Carl Ceraolo; Kathryn M Wilson; Claire H Pernar; Emily M Rencsok; Konrad H Stopsack; Sydney T Grob; Anna Plym; Edward L Giovannucci; Aria F Olumi; Adam S Kibel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-07-01       Impact factor: 4.090

Review 3.  Active surveillance review: contemporary selection criteria, follow-up, compliance and outcomes.

Authors:  Maria Komisarenko; Lisa J Martin; Antonio Finelli
Journal:  Transl Androl Urol       Date:  2018-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.